WCG ACADEMY COURSE OVERVIEW

Similar documents
TOP 10 INVESTIGATOR RESPONSIBILITIES WHEN CONDUCTING HUMAN SUBJECTS RESEARCH

Ethics Committees/IRBs Today: Challenges for Efficiency and Quality

The Role of the IRB in Clinical Trials: What Patients and Families Need to Know. Marjorie A. Speers, Ph.D. Executive Director, WCG Foundation

Human Research Protection Program. Investigator Manual

SOCIAL & BEHAVIORAL TEMPLATE WITH INSTRUCTIONS: 2.0 Background / Literature Review / Rationale for the study:

1 The Clinical Research Coordinator (CRC)... 1

Human Research Protection Program Policy

GOOD CLINICAL PRACTICE (GCP) Series Catalog

Streamlining IRB Procedures for Expanded Access

Ethical Principles in Clinical Research

\\NAS1\George\Docs\SoCRA\CCRP communications\study guide management

PREP Course 24: Defining the Differences between FDA and OHRP regulations. Presented by: Hallie Kassan Dorean Flores Office of the IRB

Annual Research Administrators Symposium IRB Compliance. Thursday, July 31, 2014

Top Ten Investigator Responsibilities When Conducting Human Subjects Research

APPLICATION INSTRUCTIONS INSTITUTIONAL REVIEW BOARD. Revised January 2010 Page 1

University of the Virgin Islands Institutional Review Board (IRB) IRB Basics for Social Science Senior Seminar (STT/STX)

Human Research Protection Program Plan

Research: Ethics, Informed Consent, FDA, Off Label Use

Advocate Health Care Network. Human Research Protection Program. Plan

Human Subjects Protection: Training for Research Teams

Elyse I. Summers, J.D. President and CEO. Copyright 2018 AAHRPP All rights reserved.

Effective Date: April 2014 Revision: September 29, 2017

2013 Metrics on Human Research Protection Program Performance

Trends in Oversight of Human Research Protections?

What is an IRB (Institutional Review Board)?

Ethical Principles in Clinical Research. Disclaimer. Christine Grady Department of Bioethics NIH Clinical Center

Human Subjects Protection Program Plan

Human Research Protection Program. Plan

Hospital Authority (HA) Guide on Research Ethics (for Study Site & Research Ethics Committee)

Volunteering for Clinical Trials

Human Subjects Research: IRB Resources

Using CITI Program Content: Good Clinical Practice (GCP)

Conducted Under an IND to Support a

IDENTIFYING & MANAGING GCP COMPLIANCE RISKS FOR THE PHARMACEUTICAL, BIOTECH & DEVICE INDUSTRIES

11.0 FDA-Regulated Research Research Involving Investigational Drugs and Biologics

Investigator Manual. Human Subjects Protection Program

Rules of Human Experimentation

11.0 FDA-Regulated Research Research Involving Investigational Drugs and Biologics

How did it evolve? o Public disasters, serious fraud and abuse of human rights. o Trials of War criminals-nuremberg code 1949

Human Research Protections Program Policies and Standard Operating Procedures

Applicability of US Regulations to Canadian Research

CHECKLIST: Pre-review

Device research sponsors, whether companies or investigators, are held responsible for meeting the same regulations.

3.1. Overall Principal Investigator (PI), who holds the IDE and/or is the Sponsor

EU Clinical Trials Regulation 536/2014

Standard Operating Procedures Guidelines for Good Clinical Practice

11.0 FDA-Regulated Research

Clinical Research with Drugs/Biologics and Devices & Good Clinical Practices

Sponsor-Investigator Responsibilities In Clinical Trials

Ethics in CTs. The Role of the Regulator versus The Role of the REB

Human Research Protection Program. Plan

Clinical Trials Management for Molecular Diagnostics. April 2016

Protocol Submission Form

HUMAN RESEARCH PROTECTION PROGRAM PLAN

EIGHT BASIC ELEMENTS OF INFORMED CONSENT

SITE SUBMISSION FORM (SINGLE SITE)

Quality Assurance for the Research Team: Connecting Day-to-Day Operations to a Regulatory Framework

FDA Perspective on International Clinical Trials

GCP Basics - refresher

World Medical Association Declaration of Helsinki

Ethical Oversight of Human Subject Research. Susan Burner Bankowski, MS,JD OHSU IRB Chair Director, Research Ethics Program

WMA Declaration of Helsinki - Ethical

APPLICATION FORM. Application for a Recognised Research Ethics Committee (REC) Opinion on a Clinical Trial on a Medicinal Product for Human Use.

Northwestern University HSPP Policy Manual Page 2 of 116

GW Policy on Human Research Protection Program

Troubleshooting Informed Consent. Sandra Meadows, MPH, CIP Office of Responsible Research Practices June 26, 2018

National Health Research Systems and Regulations for Ethical Research in Indonesia

1. POLICY STATEMENT: 2. BACKGROUND:

Sponsor/Investigator Responsibilities

PARTICIPANT RIGHTS AND PRIVACY. Tammy Stewart, CHRC & Jenny Bernhard, CHPC, CHC

Biomedical Research on Human Participants

4.2. Investigator Regulatory Binder: Files, usually a binder, maintained by the investigator at the investigative site.

UC DAVIS OFFICE OF RESEARCH AAHRPP Preparation UC Davis Human Research Part III Investigator Manual. Cindy Gates IRB Administration

The Human Biomedical Research Act: Compliance and Risks. A/Prof Goh Yeow Tee Singapore Research Ethics Conference

RESEARCH PERFORMANCE SITES AND COLLABORATIVE OFF-SITE RESEARCH

Competent federal higher authority ("Bundesoberbehörde- BOB")

GCP Convergence Improves Transportability of Medical Device Clinical Data

Research Professionals Network Workshop Series

S A I N T M A RY S E M I N A RY O C T O B E R 1 9,

INVESTIGATIONAL DEVICE EXEMPTION APPLICATION. IDE Title (if title being used)

Institutional Review Board. HRP Investigator Manual

ICH GCP E6(R2): Changes? Yes Challenges? Not as Difficult as You May Fear Lorrie D. Divers, President QRCP Solutions, Inc.

Learning about Clinical Trials

IRB HUMAN SUBJECTS PROTECTION PROGRAM STANDARD OPERATING PROCEDURES INSTITUTIONAL REVIEW BOARD

Return of Results Aggregate and Individual

Audit and Regulatory Inspection Nopanan Yaibuathes Clinical Research and Compliance Manager Roche Thailand Ltd.

INVESTIGATOR HANDBOOK

FDA Sponsor and Investigator Responsibility Checklist

Institutional Review Board Compliance Elizabeth City State University

Research Data Sharing and Security: The Challenges We Face. Jon Mark Hirshon, MD, PhD, MPH Senior Vice-Chair Institutional Review Board

HANDBOOK FOR GOOD CLINICAL RESEARCH PRACTICE (GCP)

Institutional Review Board (IRB)

WMA Declaration of Helsinki Ethical Principles f or Medical Research Involving Human Subjects

Investigator Manual Revised September 5, 2017

What s New in GCP? FDA Clarifies, Expands Safety Reporting Guidance

Objectives Discuss the importance of proper data collection. Identify the types of data collected for clinical trials. List potential source documents

Expanded Access. to Investigational Drugs & Biologics. for Treatment Use

EU Regulatory Perspective

PROTOCOL DRAFTING GUIDE

RESEARCH DURING PUBLIC HEALTH EMERGENCIES- ETHICAL ISSUES

Transcription:

WCG ACADEMY COURSE OVERVIEW Investigator Course Title Documentation of Informed Consent Duration Ethical Principles Underlying Consent Documentation Long Form Short Form Consent Records Special Considerations o Children (Assent Documentation) o Adults Unable to Consent (Assent Documentation) o Non-English Speaking Adults (Consent Documentation) o Illiterate Subjects (Consent Documentation) Course Description: The informed consent process is an integral part of clinical research. In order for research to begin, documentation of a subject s informed consent must be obtained. This course helps explain the documentation needed. Informed Consent Process WCG 20 minutes Ethical Principles Underlying Consent General Consent Special Considerations o Children Assent o Parental Permission o Assent of Adults Unable to Consent o Consent of Legally Authorized Representatives Course Description: The course introduces the informed consent process and its integral part in clinical research. The informed consent process helps ensure subjects make informed decisions and their continued participation in research.

Investigator Obligations Ethical Principles Underlying Investigator Obligations Key Terms Resources Submit and Report Equitable Selection Vulnerable and Special Populations o Children o Pregnant Women and Fetuses o Prisoners o Adults Unable to Consent o Other Vulnerable Populations Additional Obligations Course Description: This course describes the responsibilities and obligations of investigators conducting research overseen by an Institutional Review Board (IRB). GCP/ICH Obligations of Sponsors, Monitors and Investigators (GCP01) This ICH E6 GCP Investigator Site Training meets the Minimum Criteria for ICH GCP Investigator Site Personnel Training identified by TransCelerate BioPharma as necessary to enable mutual recognition of GCP training among trial sponsors. Obligations of a sponsor in conducting a clinical research programs Responsibilities of a monitor in conducting clinical investigations Obligations of an investigator in conducting clinical investigations Course Description: Addresses the obligations of sponsors, monitors and investigators who participate in clinical research governed by US FDA regulations and ICH guidelines. Communicates how human subjects are protected during clinical investigations to ensure their ongoing welfare.

Obligations of Investigators in Conducting Drug and Biologic Trials (GCP02) Research Phases Obligations of clinical investigators under GCP regulations Investigator s reporting and documentation requirements Investigator s obligation for product accountability Inspections the investigator should be prepared for Consequences of failing to comply with GCP obligations and HIPAA in the USA. Course Description: Addresses compliance with GCP regulations when conducting clinical trials for investigational new drug and biologics. Addresses the investigator s obligation to protect human subjects who participate in clinical trials, as well as, the handling of safety data, drug accountability, clinical reporting requirements and compliance with FDA regulations and ICH guidelines. Obligations of Investigators in Conducting Medical Device Trials (GCP03) 90 minutes Protocol Reporting Documentation Inspections Non-Compliance Course Description: Addresses requirements for conducting clinical trials for investigational premarket medical devices. Provides an overview of the clinical investigator s general and specific obligations to protect human subjects while providing valid data that sponsors may submit to regulatory authorities for approval. Introduction to documentation and reporting requirements, the inspection process, and the consequences for failure to comply with GCP guidelines.

IRB Member Course Title Introduction to the Criteria for IRB Approval Duration 15 minutes Criteria Approval Course Description: This course introduces the criteria needed for an Institutional Review Board (IRB) approval to conduct research on human subjects. Criteria for Approval 1: Risk 15 minutes Risk Minimizing Risk Course Description: Minimizing risk is always an integral part of protecting subjects during research. In order to reduce risks sound research procedures should be followed at all times. This course helps to identify ways to mitigate risk during research. Criteria for Approval 2: Risks and Benefits 20 minutes Benefits Analyzing Risks Course Description: Benefits and risks are analyzed when reviewing research. This course helps to recognize when these risks to subjects are reasonable in comparison to the potential benefit of the research.

Criteria for Approval 3: Equitable Selection 20 minutes Equitable vs. Equal Effects of Research Review Materials Course Description: There should be a fair sharing of the burdens and benefits of research. Each IRB member should consider the risks, benefits, purpose, setting, and involvement of vulnerable populations to decide when selection is equitable and when it is inequitable. This course helps determine whether the selection of subjects is equitable. Criteria for Approval 4: Informed Consent Obtain Consent Attributes Disclosures Course Description: After the IRB determines whether criteria 1 through 3 and 6 through 8 are met, the IRB should then evaluate the consent process. This course discusses the requirements of an approvable consent process. Criteria for Approval 5: Document Consent in Writing Documentation Different Forms Course Description: This course discusses the requirements of whether and how to document consent in writing.

Criteria for Approval 6: Safety of Subjects Monitor Research Review Information Course Description: Ensuring the safety of subjects is the most important part of research. This course discusses how to provide adequate research plans and provisions for monitoring the data collected to ensure the safety of subjects. Criteria for Approval 7: Privacy and Confidentiality Privacy Confidentiality Course Description: The IRB should review protocols to ensure they protect the privacy of subjects and maintain the confidentiality of data. This course discusses the ways that protocols can protect subjects privacy and maintain confidentiality of data. Criteria for Approval 8: Coercion of Vulnerable Populations Vulnerable Populations Safeguards Course Description: Research involving populations vulnerable to coercion or undue influence must include additional safeguards to protect their rights and welfare. This course discusses the recognition of vulnerable populations and steps that can be taken to protect their rights and welfare.